Beyond Automation: Vakils Roadmap for Intelligent Pharmaceutical Premedia
The pharmaceutical packaging industry is entering a new era, where validated automation, AI-assisted quality assurance and structured content are becoming essential capabilities rather than future aspirations.
At Vakils, we’ve developed a practical roadmap that builds on decades of pharmaceutical artwork expertise while embracing the opportunities presented by Artificial Intelligence.
Rather than replacing experienced specialists, our approach uses AI to reduce repetitive effort, strengthen quality assurance and support better decision-making – while ensuring expert human judgement remains central to every approval. Our roadmap is built around four complementary pillars, which include:
Today: Delivering Through Validated Automation
Our production environment already relies on validated automated workflows that consistently perform repetitive, rules-based activities while keeping experienced reviewers in control of every final decision.
Today these workflows:
- Standardise file formatting
- Automatically populate layout legends from XML data
- Generate design templates
- Perform automated comparisons between templates and finished artwork
Our next developments include automated font-size verification and enhanced text end-line validation to strengthen quality assurance even further.
Building Now: VAQA – Our AI Quality Companion
We are currently developing VAQA, Vakils’ proprietary AI-assisted Quality Assurance companion. VAQA acts as an intelligent co-pilot, analysing packaging files for consistency, completeness and layout compliance while highlighting potential issues for human review. Every recommendation is reviewed by trained specialists, ensuring that expert judgement – not AI – remains central to every approval decision.
Looking Ahead: Predictive Packaging AI
The next evolution of pharmaceutical premedia will move beyond identifying issues to predicting them before they occur. Drawing on decades of accumulated quality data, Vakils is developing predictive AI capabilities that will help teams identify risks earlier and work more proactively.
Future developments include:
- Identifying recurring error patterns before they become production issues
- Providing designers with instant recommendations through an AI-powered Design Guidelines Copilot
- Exploring AI-assisted generation of initial layout concepts, always subject to human review, regulatory approval and established quality processes
The objective is not to automate creativity or regulatory judgement, but to reduce repetitive effort and allow specialists to focus on the work where their expertise delivers the greatest value.
Our Foundation: People
Technology only creates value when combined with skilled people and robust quality systems. Every AI-enabled process ultimately depends on the expertise of the people using it. Technology can improve consistency and efficiency, but professional judgement remains a human responsibility. That’s why Vakils continues to invest heavily in developing specialist capability.
Our mandatory onboarding programmes include:
- Six-week Artwork Specialist Academy
- Four-week Proofreader Academy
- Continuous Professional Development
- Learning continues well beyond onboarding through:
- A growing library of advanced training covering the complete pharmaceutical packaging lifecycle
- Regular Standard Operating Procedure (SOP) refresher programmes
- Ongoing competency development aligned with evolving customer requirements and regulatory expectations
Responsible AI by Design
We believe AI should augment professional expertise, never replace it. Our approach combines validated automation, AI-assisted decision support and expert human oversight within established quality systems. As regulatory expectations for AI governance continue to evolve, we believe the future of pharmaceutical packaging will depend on maintaining transparency, traceability and accountability alongside technological innovation.
Ultimately, the purpose of automation is not to replace expert judgement. It is to reduce repetitive manual effort, improve consistency and enable specialists to focus on the decisions that require experience, scientific understanding and regulatory expertise.
The Road Ahead
At Vakils, we’re investing in validated automation, responsible AI and specialist capability so that our clients can deliver packaging that remains accurate, compliant and patient-focused in an increasingly digital world. By combining experienced people, validated processes and intelligent technology, we believe we’re helping shape the future of pharmaceutical premedia.
If you’d like to learn more about Vakils’ approach to intelligent pharmaceutical premedia, we’d be pleased to start a conversation. Email us at info@vakilspremedia.com
